Real‐world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45‐year period-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real‐world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45‐year period

Published:2021-10-07 Issue:3 Volume:196 Page:649-659
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Rodríguez‐Lobato Luis Gerardo¹²^ORCID,Pereira Arturo³^ORCID,Fernández de Larrea Carlos¹²^ORCID,Cibeira Maria Teresa¹²^ORCID,Tovar Natalia¹²^ORCID,Jiménez‐Segura Raquel¹²^ORCID,Moreno David F.¹²^ORCID,Oliver‐Caldés Aina¹²^ORCID,Rosiñol Laura¹²^ORCID,Bladé Joan¹²^ORCID

Affiliation:

1. Amyloidosis and Multiple Myeloma Unit Department of Hematology Hospital Clínic of Barcelona BarcelonaSpain

2. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) BarcelonaSpain

3. Transfusion Medicine Department Hospital Clínic Barcelona Spain

Funder

H2020 Marie Skłodowska-Curie Actions

Instituto de Salud Carlos III

European Regional Development Fund

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17888

Reference57 articles.

1. Multiple myeloma: A review of the epidemiologic literature

2. Incidence of multiple myeloma in Olmsted County, Minnesota

3. Patterns of Multiple Myeloma During the Past 5 Decades: Stable Incidence Rates for All Age Groups in the Population but Rapidly Changing Age Distribution in the Clinic

4. Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry

5. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution;Cancers;2023-11-02

2. High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation;Frontiers in Oncology;2023-09-27

3. Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma;New England Journal of Medicine;2023-07-27

4. Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma;Cancers;2023-03-02

5. Global real-life analysis of survival and usage of therapies in multiple myeloma;2023-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3